معرفی
Professor Mary Collins is a Professor of Pharmaceutical Neuroscience at the University of Sydney, affiliated with the Sydney School of Medical Sciences. She serves as Interim Associate Dean, Research and Head of School.
- Member of the Centre for Drug Discovery Innovation
- Member of the Brain and Mind Centre
Research Interests
- GABA Receptors: Focus on subtype-selective modulators, binding site identification, and roles in anxiety, sleep disorders, and epilepsy.
- Nicotinic Acetylcholine Receptors: Structure-function studies using site-directed mutagenesis and reactive probes to understand ligand binding.
- Drug Discovery: SAR studies for selective agents targeting Cys-loop receptors, including flavonoids and cannabinoids.
Scientific Contributions
Her 15 most recent articles (2020-2024) span epilepsy genetics, receptor stoichiometry, neuroprotective flavonoids, and cannabinoid interactions. Key themes include precision medicine for receptor variants and neurotransmitter modulation in disorders.
- ASCEPT Young Investigator Award
- RACI Biota Award
- Fellow of RACI (2006)
- Supervision Award (University of Sydney, 2008)
Advising
Current students: Jacinda HOLTSMARK (epilepsy neurophysiology), Sze Hon KAN (genetic epilepsies), Fiona WANG (neurological mechanisms).
۰مقاله ثبتشده
